Stereotactic radiotherapy for early stage of non - small cell lung cancer / 实用肿瘤学杂志
Practical Oncology Journal
;
(6): 53-56, 2018.
Article
in Chinese
| WPRIM
| ID: wpr-697902
ABSTRACT
At present,approximately 20% of patients with clinically diagnosed early non-small cell lung cancer(NSCLC) are inoperable for their own reasons.Stereotactic radiotherapy(SRT)has the advantages of short treatment time,mild treatment-relat-ed injury and high local control rate. Currently,it has been used internationally as a first -line treatment for early incapacity of NSCLC.SRT has also achieved encouraging therapeutic effects in the treatment of early-stage NSCLC,but there are also some prob-lems to be solved urgently.This article aims to summarize the dosimetry,clinical indications and radiotherapy injury of SRT in the treatment of early-stage NSCLC.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Practical Oncology Journal
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS